HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.

Abstract
Cystic lung diseases constitute a distinct group of rare lung disorders, among which two result from monogenic defects affecting tumor suppressor genes: lymphangioleiomyomatosis, either sporadic or associated with tuberous sclerosis complex, and Birt-Hogg-Dubé syndrome. These disorders have similarities in their clinical expression, including occurrence in young adults, multiple pulmonary cysts, recurrent pneumothorax, skin hamartomas, and renal tumors. However, they markedly differ in their gender distribution, pathogenesis, disease course, and prognosis. Our knowledge on these two rare conditions is rapidly expanding. Management of lymphangioleiomyomatosis has substantially improved in the past decade with the understanding of its pathogenic mechanisms, the discovery of an effective therapy, and development of large cohorts and international guidelines. Birt-Hogg-Dubé syndrome has been described more recently and still awaits deeper understanding of its pathophysiology.
AuthorsCécile Daccord, Laurent P Nicod, Romain Lazor
JournalRespiration; international review of thoracic diseases (Respiration) Vol. 94 Issue 6 Pg. 467-485 ( 2017) ISSN: 1423-0356 [Electronic] Switzerland
PMID29169151 (Publication Type: Journal Article, Review)
Copyright© 2017 S. Karger AG, Basel.
Chemical References
  • FLCN protein, human
  • Proto-Oncogene Proteins
  • Tumor Suppressor Proteins
Topics
  • Birt-Hogg-Dube Syndrome (diagnostic imaging, genetics)
  • Disease Management
  • Genes, Tumor Suppressor
  • Humans
  • Lymphangioleiomyomatosis (diagnostic imaging, genetics)
  • Proto-Oncogene Proteins (genetics)
  • Radiography, Thoracic
  • Tomography, X-Ray Computed
  • Tuberous Sclerosis (diagnostic imaging, genetics)
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: